Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CN¥41,337 | CN¥0 | CN¥0 | CN¥0 |
| Dep. & Amort. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Deferred Tax | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Change in WC | CN¥0 | CN¥357,962 | CN¥0 | CN¥0 |
| Other Non-Cash | CN¥124,064 | -CN¥157,901 | -CN¥53,471 | CN¥0 |
| Operating Cash Flow | CN¥165,401 | CN¥200,061 | -CN¥53,471 | CN¥0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥200,759 | -CN¥138,857 | -CN¥330,976 | -CN¥571,221 |
| Net Acquisitions | CN¥378 | CN¥0 | CN¥0 | CN¥0 |
| Inv. Purchases | -CN¥62,771 | -CN¥8,296 | -CN¥26,000 | -CN¥79,849 |
| Inv. Sales/Matur. | CN¥0 | CN¥77,052 | CN¥1,120 | CN¥5,904 |
| Other Inv. Act. | -CN¥98,048 | -CN¥15,063 | CN¥17,775 | CN¥22,556 |
| Investing Cash Flow | -CN¥361,200 | -CN¥85,164 | -CN¥338,081 | -CN¥622,610 |
| Financing Activities | – | – | – | – |
| Debt Repay. | CN¥198,363 | -CN¥321,111 | CN¥911,480 | CN¥5,023,710 |
| Stock Issued | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock Repurch. | CN¥92,878 | -CN¥92,878 | CN¥0 | CN¥0 |
| Dividends Paid | CN¥0 | -CN¥30,363 | -CN¥30,496 | -CN¥185,015 |
| Other Fin. Act. | -CN¥124,209 | CN¥120,193 | -CN¥275,963 | -CN¥359,190 |
| Financing Cash Flow | CN¥167,032 | -CN¥324,159 | CN¥605,021 | CN¥4,479,505 |
| Forex Effect | -CN¥13,607 | -CN¥9,697 | CN¥1,785 | CN¥22,986 |
| Net Chg. in Cash | -CN¥42,375 | -CN¥218,958 | CN¥214,134 | CN¥4,485,035 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥6,863,773 | CN¥7,065,697 | CN¥6,851,563 | CN¥2,366,528 |
| End Cash | CN¥6,821,398 | CN¥6,846,739 | CN¥7,065,697 | CN¥6,851,563 |
| Free Cash Flow | -CN¥35,359 | CN¥61,204 | -CN¥385,568 | CN¥33,933 |